FROST PHILLIP MD ET AL purchased 0.2% of their position (4K shares) of COCRYSTAL PHARMA, INC. on the open market
Open‑market purchase worth $4.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/28/2025ACC: 0001493152-25-025314
Director10% Owner
Since Feb 2026
+4K
Net shares
Net buyer
$4.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.50K
Price / share
$1.00
Trade value
$1.50K
% of position
0.1%
11/26/2025
1.70M→1.70M
Common Stock
Indirect
Shares
+2.50K
Price / share
$0.99
Trade value
$2.48K
% of position
0.1%
11/26/2025
1.70M→1.70M
Total
Net shares
+4K
Net value
$3.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/26/2025 | P · Purchase | +1.50K | $1.00 | $1.50K | 0.1% | 1.70M | 1.70M |
| Common Stock Indirect | 11/26/2025 | P · Purchase | +2.50K | $0.99 | $2.48K | 0.1% | 1.70M | 1.70M |
| Total | +4K | $3.98K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned27.10K
Total
27.10K direct27.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.10K | Direct |
| Total | 27.10K | 27.10K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported